ID: ALA5271980

Max Phase: Preclinical

Molecular Formula: C17H28N6O3

Molecular Weight: 364.45

Associated Items:

Representations

Canonical SMILES:  CCCCOc1nc(N)c2[nH]c(=O)n(CCCCN3CCOCC3)c2n1

Standard InChI:  InChI=1S/C17H28N6O3/c1-2-3-10-26-16-20-14(18)13-15(21-16)23(17(24)19-13)7-5-4-6-22-8-11-25-12-9-22/h2-12H2,1H3,(H,19,24)(H2,18,20,21)

Standard InChI Key:  GPPJVROJVRJFAI-UHFFFAOYSA-N

Associated Targets(Human)

Toll-like receptor 7 2626 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.2223AlogP: 0.99#Rotatable Bonds: 9
Polar Surface Area: 111.29Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.34CX Basic pKa: 7.51CX LogP: 1.85CX LogD: 1.49
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.64Np Likeness Score: -1.17

References

1. Biggadike K, Ahmed M, Ball DI, Coe DM, Dalmas Wilk DA, Edwards CD, Gibbon BH, Hardy CJ, Hermitage SA, Hessey JO, Hillegas AE, Hughes SC, Lazarides L, Lewell XQ, Lucas A, Mallett DN, Price MA, Priest FM, Quint DJ, Shah P, Sitaram A, Smith SA, Stocker R, Trivedi NA, Tsitoura DC, Weller V..  (2016)  Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.,  59  (5): [PMID:26861551] [10.1021/acs.jmedchem.5b01647]

Source